Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary open-angle glaucoma.

Robert N Weinreb1, Peng Tee Khaw

  • 1Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946, USA. weinreb@eyecenter.ucsd.edu

Lancet (London, England)
|May 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cohort profile: Design and methods for Project HERCULES (Healthcare Exemplar for Recovery from COVID 19 Using Linear Examination Systems): Multi-disciplinary implementation and evaluation of an asynchronous review clinic in NHS eye-care services.

PloS one·2025
Same author

Impact of a community-based asynchronous review clinic on appointment attendance delays across an eye hospital network in London, UK: an interrupted time series analysis.

BMJ open·2025
Same author

Rho Kinase (ROCK) Inhibitors in the Treatment of Glaucoma and Glaucoma Surgery: A Systematic Review of Early to Late Phase Clinical Trials.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Exploring the potential of rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice.

Survey of ophthalmology·2025
Same author

Real-Time Monitoring Platform for Ocular Drug Delivery.

Pharmaceutics·2023
Same author

Long-Term Safety and Outcomes of β-radiation for Trabeculectomy.

Journal of glaucoma·2022
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026
See all related articles

Early detection of primary open-angle glaucoma is crucial for preventing irreversible vision loss. Lowering intraocular pressure effectively halts glaucoma progression, with improved therapies and neuroprotective treatments in development.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Primary open-angle glaucoma is a common, progressive optic neuropathy.
  • Early detection is vital due to irreversible visual impairment.
  • Diagnosis relies on optic disc, retinal nerve fiber layer, and visual field examination.

Purpose of the Study:

  • To review current diagnostic and therapeutic strategies for primary open-angle glaucoma.
  • To highlight the importance of early detection and intraocular pressure management.

Main Methods:

  • Review of recent clinical trials and therapeutic advancements.
  • Discussion of new imaging and psychophysical tests for glaucoma detection and monitoring.

Main Results:

  • Long-term trials confirm that lowering intraocular pressure prevents glaucoma progression.

Related Experiment Videos

  • Therapeutic improvements include better drugs and surgical procedures.
  • New treatments targeting retinal ganglion cell protection are under development.

    • Conclusions:

    • Early diagnosis and consistent lowering of intraocular pressure are key to managing primary open-angle glaucoma.
    • Advancements in diagnostics and therapeutics offer improved patient outcomes.